Seizure Therapy Quantification via Multivariate Variable Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current epilepsy treatment methods lack effective tools for quantitatively assessing the impact of various independent variables on seizure-dependent variables, such as therapy efficacy and adverse effects, which limits the optimization of seizure therapies.

Innovation Solution

A medical device system and method that acquires and quantifies data on dependent and independent variables, including therapy parameters, temporal, environmental, and patient factors, to assess therapy efficacy and provide responsive actions like modifying treatment recommendations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional epilepsy treatment assessment methods are used, then treatment monitoring is simple, but the precision of therapy efficacy assessment is insufficient

Engineering Contradiction:
Improvetherapy efficacy assessment precisionVSAvoidassessment system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the therapy assessment into multiple independent variable categories (therapy parameters, delivery parameters, temporal factors, environmental factors, patient factors) and dependent variable categories (seizure frequency, intensity, duration, spread, adverse effects). This segmentation allows systematic analysis of each factor's contribution to therapy outcomes while maintaining overall system manageability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a data quantification unit as an intermediary component that processes raw clinical data and computes quantitative relationships between independent and dependent variables. This intermediary layer translates complex multivariate data into interpretable metrics, enabling precise therapy assessment without requiring direct complex system architecture.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If multiple variables are monitored to assess therapy impact, then assessment comprehensiveness is improved, but data processing complexity increases

Engineering Contradiction:
Improveassessment comprehensivenessVSAvoiddata processing complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent creates a universal data quantification framework that handles multiple types of variables (therapy parameters, delivery parameters, temporal factors, environmental factors, patient factors) through a single integrated approach. This multi-functional system can assess various therapy aspects (efficacy, adverse effects, optimal dosing) using the same quantitative methodology, reducing the need for separate specialized systems.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent implements feedback mechanisms where the quantified relationships between variables are used to generate therapy modification recommendations. The system continuously monitors dependent variables, compares them against target ranges, and provides feedback loops that adjust independent variables (therapy parameters) to optimize outcomes, thereby managing complexity through automated control.

Inventive Principle:
Principle #23Feedback

3Productivity

If quantitative analysis of multiple factors is performed, then therapy optimization capability is enhanced, but computational requirements increase

Engineering Contradiction:
Improvetherapy optimization capabilityVSAvoidcomputational power requirements
Core Design Contradiction:
ProductivityVSPower

Solution Approach 1:

The patent applies partial action by focusing quantitative analysis on the most clinically relevant relationships between variables rather than computing all possible combinations. The system identifies key dependent variables (seizure frequency, intensity, duration) and prioritizes analysis of their relationships with independent variables, performing sufficient but not excessive computation to achieve meaningful therapy optimization.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20190328262A1Quantitative multivariate analysis of seizures
Publication Date: 2019.10.31 FLINT HILLS SCIENTIFIC LLC
  • US20190328262A1 patent drawing
  • US20190328262A1 patent drawing
  • US20190328262A1 patent drawing

AI summary

Methods, including a method, comprising selecting a plurality of dependent variables relating to each of a plurality of seizures in a patient; selecting a plurality of independent variables, wherein each independent variable comprises a therapy parameter, a therapy delivery parameter, a temporal factor, an environmental factor, or a patient factor; quantifying at least one relationship between each of at least two dependent variables and each of at least two independent variables; and performing an action in response to said quantifying, selected from reporting said at least one relationship, assessing an efficacy of a therapy, assessing an adverse effect of said therapy, providing a therapy modification recommendation, or adjusting said therapy. A medical device system capable of implementing a method. A non-transitory computer readable program storage medium containing instructions that, when executed by a computer, perform a method.